Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Urology Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1215045C discloses high-purity crystalline salts of 3,3-diphenylpropylamine derivatives, offering superior stability and bioavailability for urinary incontinence treatments.